Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice

Journal of Clinical Investigation

Volumn 111, Issue 9, 2003, Pages 1297-1308

  Kobayashi, Masaya ^a   Kweon, Mi Na ^a   Kuwata, Hirotaka ^a   Schreiber, Robert D ^b   Kiyono, Hiroshi ^a,c   Takeda, Kiyoshi ^a,d   Akira, Shizuo ^a,d  

^a OSAKA UNIVERSITY   (Japan)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; PROTEIN P40; RAG2 PROTEIN; STAT3 PROTEIN; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL SPECIFICITY; CELLULAR IMMUNITY; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTEROCOLITIS; GENE DELETION; GENE MUTATION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFLAMMATION; INTERFERON PRODUCTION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; TH1 CELL;

EID: 0037799912     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI17085     Document Type: Article

References (53)

1. Podolsky, D.K. 1991. Inflammatory bowel disease. N. Engl. J. Med. 325:928-937.
2. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., and Muller, W. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:263-274.
3. Mombaerts, P., et al. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell. 75:274-282.
4. Wirtz, S., et al. 1999. Cutting edge: Chronic intestinal inflammation in STAT-4 cransgenic mice: characterization of disease and adoptive transfer by TNF-plus IFN-γ-producing CD4+ T cells that respond to bacterial antigens. J. Immunol. 162:1884-1888.
5. Neurath, M.F., et al. 2002. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195:1129-1143.
6. Neurath, M.F., Finotto, S., and Glimcher, L.H. 2002. The role of Th1/Th2 polarization in mucosal immunity. Nat. Med. 8:567-573.
7. Scrober, W., Fuss, I.J., and Blumberg, R.S. 2002. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20:495-549.
8. Berg, D.M., et al. 1996. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. Invest. 98:1010-1020.
9. Davidson, N.J., et al. 1996. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J. Exp. Med. 184:241-251.
10. Davidson, N.J., et al. 1998. IL-12, but not IFN-γ, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J. Immunol. 161:3143-3149.
11. Moore, K.W., de Waal Malefyt, R., Coffman, R.L., and O'Garra, A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683-765.
12. Asseman, C., Mauze, S., Leach, M.W, Coffman, R.L., and Powrie, F. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190:995-1004.
13. Maloy, K.J., and Powrie, F. 2001. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:816-822.
14. Takeda, K., and Akira, S. 2000. STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev. 11:199-207.
15. O'Shea, J.J., Gadina, M., and Schreiber, R.D. 2002. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell. 109:S121-131.
16. Takeda, K., et al. 1997. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. U. S. A. 94:3801-3804.
17. Takeda, K., et al. 1998. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: Generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 161:4652-4660.
18. Akira, S. 2000. Roles of STAT3 defined by tissue-specific gene targeting. Oncogene. 19:2607-2611.
19. Levy, D.E., and Lee, C. 2002. What does Stat3 do? J. Clin. Invest. 109:1143-1148. doi:10.1172/JC200215650.
20. Takeda, K., et al. 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity. 10:39-49.
21. Meraz, M.A., et al. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 84:431-442.
22. Magram, J., et al. 1996. IL-12-deficient mice are defective in IFNγ production and type 1 cytokine responses. Immunity. 4:471-481.
23. Tagawa, Y., Sekikawa, K., and Iwakura, Y. 1997. Suppression of concanavalin A-induced hepatitis in IFN-γ (-/-) mice, but not in TNF-α (-/-) mice: role for IFN-γ in activating apoptosis of hepatocytes. J. Immunol. 159:1418-1428.
24. Hoshino, K., et al. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749-3752.
25. + T cells in a transfer model of colitis. J. Immunol. 161:3256-3261.
26. + T cells. Gut. 50:299-306.
27. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411-452.
28. Janeway, C.A., Jr., and Medzhitov, R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216
29. Akira, S., Takeda, K., and Kaisho, T. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675-680.
30. Poltorak, A., et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/IOScCr mice: mutation in Tlr4 gene. Science. 282:2085-2088.
31. Lang, R., Patel, D., Morris, J.J., Rutschman, R.L., and Murray, P.J. 2002. Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 169:2253-2263.
32. Berlato, C., et al. 2002. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J. Immunol. 168:6404-6411.
33. Oppmann, B., et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 13:715-725.
34. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:737-742.
35. Targan, S.R, et al. 1997. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. N. Engl. J. Med. 337:1029-1035.
36. Kontoyiannis, D., Pasparakis, M., Pizarro, T.T., Cominelli, F., and Kollias, G. 1999. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity. 10:387-398.
37. Plevy, S.E., et al. 1997. A role for TNF-α and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J. Immunol. 159:6276-6282.
38. Papadakis, K.A., and Targan, S.R. 2000. Role ofcytokines in the pathogenesis of inflammatory bowel diseases. Annu. Rev. Med. 51:289-298.
39. Davidson, N.J., Fort, M.M., Müller, W., Leach, M.W., and Rennick, D.M. 2000. Chronic colitis in IL-10-/-mice: insufficient counter regulation of a Th1 response. Int. Rev. Immunol. 19:91-121.
40. Kontoyiannis, D., et al. 2001. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J. 20:3760-3770.
41. Rothe, J., et al. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature. 364:798-802
42. Pfeffer, K., et al. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 73:457-467.
43. Gil, M.P., et al. 2001. Biologic consequences of Stat1-independent IFN signaling. Proc. Natl. Acad. Sci. U. S. A. 98:6680-6685.
44. Ramana, C.V., et al. 2000. Regulation ofc-myc expression by IFN-γthrough Stat1-dependent and -independent pathways. EMBO J. 19:263-272.
45. Ramana, C.V., et al. 2001. Stat1-independent regulation of gene expression in response to IFN-γ. Proc. Natl. Acad. Sci. U. S. A. 98:6674-6679.
46. Ramana, C.V., Gil, M.P., Schreiber, R.D., and Stark, G.R. 2002. Stat1-dependent and -independent pathways in IFN-γ-dependent signaling. Trends Immunol. 23:96-101.
47. Simpson, S.J., et al. 1998. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. J. Exp. Med. 187:1225-1234.
48. Sellon, R.K., et al. 1998. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66:5224-5231.
49. Madsen, K.L., et al. 2000. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology. 118:1094-1105.
50. Hemmi, H., et al. 2000. A Toll-like receptor recognizes bacterial DNA. Nature. 408:740-745.
51. Hayashi, F., et al. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 410:1099-1103.
52. Gewirtz, A.T., Navas, T.A., Lyons, S., Godowski, P.J., and Madara, J.L. 2001. Cutting edge: Bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167:1882-1885.
53. Rescigno, M., et al. 2001. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2:361-367.